The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Trifonov S.A.

Vishnevsky Center of Surgery

Gorokhov A.I.

Vishnevsky National Medical Research Center of Surgery

Gurmikov B.N.

Vishnevsky National Medical Research Center of Surgery

Vishnevsky V.A.

Vishnevsky National Medical Research Center of Surgery

Hepatic hemangioma: what surgeons need to know

Authors:

Trifonov S.A., Gorokhov A.I., Gurmikov B.N., Vishnevsky V.A.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2025;(11): 102‑108

Read: 538 times


To cite this article:

Trifonov SA, Gorokhov AI, Gurmikov BN, Vishnevsky VA. Hepatic hemangioma: what surgeons need to know. Pirogov Russian Journal of Surgery. 2025;(11):102‑108. (In Russ.)
https://doi.org/10.17116/hirurgia2025111102

Recommended articles:
Lapa­roscopic ALPPS procedure: a series of cases. Piro­gov Russian Journal of Surgery. 2025;(2):20-26
Mini­mally inva­sive surgery for liver echi­nococcosis. Piro­gov Russian Journal of Surgery. 2025;(9):61-68
Liver invo­lvement in Gaucher disease in children: A lite­rature review and clinical obse­rvations. Russian Journal of Evidence-Based Gastroenterology. 2025;(2):78-93

References:

  1. Karhunen PJ. Benign hepatic tumours and tumour like conditions in men. J Clin Pathol. 1986;39(2):183-188.  https://doi.org/10.1136/jcp.39.2.183
  2. Fodor M, Primavesi F, Braunwarth E, et al. Indications for liver surgery in benign tumours. Eur Surg. 2018;50(3):125-131.  https://doi.org/10.1007/s10353-018-0536-y
  3. Belghiti J, Cauchy F, Paradis V, Vilgrain V. Diagnosis and management of solid benign liver lesions. Nat Rev Gastroenterol Hepatol. 2014;11(12):737-749.  https://doi.org/10.1038/nrgastro.2014.151
  4. Mori H, Ikegami T, Imura S, et al. Sclerosed hemangioma of the liver: Report of a case and review of the literature. Hepatol Res. 2008;38(5): 529-533.  https://doi.org/10.1111/j.1872-034X.2007.00306.x
  5. European Association for the Study of the Liver (EASL). EASL Clinical Practice Guidelines on the management of benign liver tumours. J Hepatol. 2016;65(2):386-398.  https://doi.org/10.1016/j.jhep.2016.04.001
  6. Leon M, Chavez L, Surani S. Hepatic hemangioma: What internists need to know. World J Gastroenterol. 2020;26(1):11-20.  https://doi.org/10.3748/wjg.v26.i1.11
  7. Di Carlo I, Koshy R, Al Mudares S, Ardiri A, Bertino G, Toro A. Giant cavernous liver hemangiomas: is it the time to change the size categories? Hepatobiliary Pancreat Dis Int. 2016;15(1):21-29.  https://doi.org/10.1016/s1499-3872(15)60035-2
  8. Yang Z, Tan H, Liu X, Sun Y. Extremely Giant Liver Hemangioma (50 cm) with Kasabach-Merritt Syndrome. J Gastrointest Surg. 2017; 21(10):1748-1749. https://doi.org/10.1007/s11605-017-3429-7
  9. Moser C, Hany A, Spiegel R. Familiäre Riesenhämangiome der Leber. Untersuchung einer Familie und Literaturübersicht Familialgianthemangiomasoftheliver.Studyofafamilyandreviewoftheliterature].Praxis(Bern1994).1998;87(14):461-468.(InGerman).
  10. Lee M, Choi JY, Lim JS, Park MS, Kim MJ, Kim H. Lack of anti-tumor activity by anti-VEGF treatments in hepatic hemangiomas. Angiogenesis. 2016;19(2):147-153.  https://doi.org/10.1007/s10456-016-9494-9
  11. Glinkova V, Shevah O, Boaz M, Levine A, Shirin H. Hepatic haemangiomas: possible association with female sex hormones. Gut. 2004;53(9):1352-1355. https://doi.org/10.1136/gut.2003.038646
  12. Ozakyol A, Kebapci M. Enhanced growth of hepatic hemangiomatosis in two adults after postmenopausal estrogen replacement therapy. Tohoku J Exp Med. 2006;210(3):257-261.  https://doi.org/10.1620/tjem.210.257
  13. Jing L, Liang H, Caifeng L, et al. New recognition of the natural history and growth pattern of hepatic hemangioma in adults. Hepatol Res. 2016;46(8):727-733.  https://doi.org/10.1111/hepr.12610
  14. Marrero JA, Ahn J, Rajender Reddy K; Americal College of Gastroenterology. ACG clinical guideline: the diagnosis and management of focal liver lesions. Am J Gastroenterol. 2014;109(9):1328-1348. https://doi.org/10.1038/ajg.2014.213
  15. Sakamoto Y, Kokudo N, Watadani T, et al. Proposal of size-based surgical indication criteria for liver hemangioma based on a nationwide survey in Japan. J Hepatobiliary Pancreat Sci. 2017;24(7):417-425.  https://doi.org/10.1002/jhbp.464
  16. Oldhafer KJ, Habbel V, Horling K, Makridis G, Wagner KC. Benign Liver Tumors. Visc Med. 2020;36(4):292-303.  https://doi.org/10.1159/000509145
  17. Luks FI, Yazbeck S, Brandt ML, Bensoussan AL, Brochu P, Blanchard H. Benign liver tumors in children: a 25-year experience. J Pediatr Surg. 1991;26(11):1326-1330. https://doi.org/10.1016/0022-3468(91)90612-w
  18. Bornman PC, Terblanche J, Blumgart RL, Jones EP, Pickard H, Kalvaria I. Giant hepatic hemangiomas: diagnostic and therapeutic dilemmas. Surgery. 1987;101(4):445-449. 
  19. Liu X, Yang Z, Tan H, Zhou W, Su Y. Fever of Unknown Origin Caused by Giant Hepatic Hemangioma. J Gastrointest Surg. 2018;22(2):366-367.  https://doi.org/10.1007/s11605-017-3522-y
  20. Smith AA, Nelson M. High-Output Heart Failure from a Hepatic Hemangioma With Exertion-Induced Hypoxia. Am J Cardiol. 2016;117(1): 157-158.  https://doi.org/10.1016/j.amjcard.2015.10.019
  21. Mocchegiani F, Vincenzi P, Coletta M, et al. Prevalence and clinical outcome of hepatic haemangioma with specific reference to the risk of rupture: A large retrospective cross-sectional study. Dig Liver Dis. 2016;48(3):309-314.  https://doi.org/10.1016/j.dld.2015.09.016
  22. Uetama T, Yoshida H, Hirakata A, et al. A symptomatic giant hepatic hemangioma treated with hepatectomy. J Nippon Med Sch. 2011; 78(1):34-39.  https://doi.org/10.1272/jnms.78.34
  23. Mamone G, Di Piazza A, Carollo V, et al. Imaging of hepatic hemangioma: from A to Z. Abdom Radiol (NY). 2020;45(3):672-691.  https://doi.org/10.1007/s00261-019-02294-8
  24. Toro A, Mahfouz AE, Ardiri A, et al. What is changing in indications and treatment of hepatic hemangiomas. A review. Ann Hepatol. 2014; 13(4):327-339. 
  25. Klotz T, Montoriol PF, Da Ines D, Petitcolin V, Joubert-Zakeyh J, Garcier JM. Hepatic haemangioma: common and uncommon imaging features. Diagn Interv Imaging. 2013;94(9):849-859.  https://doi.org/10.1016/j.diii.2013.04.008
  26. Lim KJ, Kim KW, Jeong WK, et al. Colour Doppler sonography of hepatic haemangiomas with arterioportal shunts. Br J Radiol. 2012; 85(1010):142-146.  https://doi.org/10.1259/bjr/96605786
  27. Yamashita Y, Ogata I, Urata J, Takahashi M. Cavernous hemangioma of the liver: pathologic correlation with dynamic CT findings. Radiology. 1997;203(1):121-125.  https://doi.org/10.1148/radiology.203.1.9122378
  28. Mamone G, Miraglia R. The “light bulb sign” in liver hemangioma. Abdom Radiol (NY). 2019;44(6):2327-2328. https://doi.org/10.1007/s00261-019-01964-x
  29. Terriff BA, Gibney RG, Scudamore CH. Fatality from fine-needle aspiration biopsy of a hepatic hemangioma. AJR Am J Roentgenol. 1990;154(1):203-204.  https://doi.org/10.2214/ajr.154.1.2104717
  30. Davies R. Haemorrhage after fine-needle aspiration biopsy of an hepatic haemangioma. Med J Aust. 1993;158(5):364.  https://doi.org/10.5694/j.1326-5377.1993.tb121823.x
  31. Taavitsainen M, Airaksinen T, Kreula J, Päivänsalo M. Fine-needle aspiration biopsy of liver hemangioma. Acta Radiol. 1990;31(1):69-71. 
  32. Hasan HY, Hinshaw JL, Borman EJ, Gegios A, Leverson G, Winslow ER. Assessing normal growth of hepatic hemangiomas during long-term follow-up [published correction appears in JAMA Surg. 2014;149(12):1271]. JAMA Surg. 2014;149(12):1266-1271. https://doi.org/10.1001/jamasurg.2014.477
  33. Bajenaru N, Balaban V, Săvulescu F, Campeanu I, Patrascu T. Hepatic hemangioma. Review. J Med Life. 2015;8(Spec Issue):4-11. 
  34. Etemadi A, Golozar A, Ghassabian A, et al. Cavernous hemangioma of the liver: factors affecting disease progression in general hepatology practice. Eur J Gastroenterol Hepatol. 2011;23(4):354-358.  https://doi.org/10.1097/MEG.0b013e3283451e7d
  35. Cheng WL, Qi YQ, Wang B, Tian L, Huang W, Chen Y. Enucleation versus hepatectomy for giant hepatic haemangiomas: a meta-analysis. Ann R Coll Surg Engl. 2017;99(3):237-241.  https://doi.org/10.1308/rcsann.2016.0349
  36. Ghosh NK, R R, Singh A, et al. Surgery for symptomatic hepatic hemangioma: Resection vs. enucleation, an experience over two decades. Ann Hepatobiliary Pancreat Surg. 2023;27(3):258-263.  https://doi.org/10.14701/ahbps.22-130
  37. Liu Y, Wei X, Wang K, et al. Enucleation versus Anatomic Resection for Giant Hepatic Hemangioma: A Meta-Analysis. Gastrointest Tumors. 2017;3(3-4):153-162.  https://doi.org/10.1159/000455846
  38. Zhang Z, Ji J, Qiu G, et al. Surgical indications for solid hepatic benign tumors: An updated literature review. Biosci Trends. 2023;17(5):325-334.  https://doi.org/10.5582/bst.2023.01152
  39. Jiang B, Shen ZC, Fang XS, Wang XM. Enucleation versus hepatectomy for hepatic hemangiomas: A meta-analysis. Front Surg. 2022; 9:960768. https://doi.org/10.3389/fsurg.2022.960768
  40. Fu XH, Lai EC, Yao XP, et al. Enucleation of liver hemangiomas: is there a difference in surgical outcomes for centrally or peripherally located lesions? Am J Surg. 2009;198(2):184-187.  https://doi.org/10.1016/j.amjsurg.2008.09.029
  41. Liu Q, Liu F, Ding J, Wei Y, Li B. Surgical outcomes and quality of life between laparoscopic and open approach for hepatic hemangioma: A propensity score matching analysis. Medicine (Baltimore). 2019;98(6):e14485. https://doi.org/10.1097/MD.0000000000014485
  42. Sundar Alagusundaramoorthy S, Vilchez V, Zanni A, et al. Role of transplantation in the treatment of benign solid tumors of the liver: a review of the United Network of Organ Sharing data set. JAMA Surg. 2015;150(4):337-342.  https://doi.org/10.1001/jamasurg.2014.3166
  43. Prodromidou A, Machairas N, Garoufalia Z, et al. Liver Transplantation for Giant Hepatic Hemangioma: A Systematic Review. Transplant Proc. 2019;51(2):440-442.  https://doi.org/10.1016/j.transproceed.2019.01.018
  44. Tarazov PG, Polysalov VN, Ryzhkov VK. Hemangiomatosis of the liver and spleen: successful treatment with embolization and splenectomy. AJR Am J Roentgenol. 1990;155(6):1235-1236. https://doi.org/10.2214/ajr.155.6.2122671
  45. Dong W, Qiu B, Xu H, He L. Invasive management of symptomatic hepatic hemangioma. Eur J Gastroenterol Hepatol. 2019;31(9):1079-1084. https://doi.org/10.1097/MEG.0000000000001413
  46. Özden İ, Poyanlı A, Önal Y, Demir AA, Hoş G, Acunaş B. Superselective Transarterial Chemoembolization as an Alternative to Surgery in Symptomatic/Enlarging Liver Hemangiomas. World J Surg. 2017;41(11):2796-2803. https://doi.org/10.1007/s00268-017-4069-5
  47. Akhlaghpoor S, Torkian P, Golzarian J. Transarterial Bleomycin-Lipiodol Embolization (B/LE) for Symptomatic Giant Hepatic Hemangioma. Cardiovasc Intervent Radiol. 2018;41(11):1674-1682. https://doi.org/10.1007/s00270-018-2010-4
  48. Liu X, Yang Z, Tan H, et al. Long-term result of transcatheter arterial embolization for liver hemangioma. Medicine (Baltimore). 2017;96(49):e9029. https://doi.org/10.1097/MD.0000000000009029
  49. Jin S, Shi XJ, Sun XD, Wang SY, Wang GY. Sclerosing cholangitis secondary to bleomycin-iodinated embolization for liver hemangioma. World J Gastroenterol. 2014;20(46):17680-17685. https://doi.org/10.3748/wjg.v20.i46.17680
  50. Shi QS, Xing LX, Jin LF, Wang H, Lv XH, Du LF. Imaging findings of bile duct hamartomas: a case report and literature review. Int J Clin Exp Med. 2015;8(8):13145-13153.
  51. Lopatin YaR, Petrov NA, Dzidzava II, et al. Prognozirovanie effektivnosti transkateternoj arterialnoj embolizatsii gemangiom pecheni. Izvestiya Rossijskoj voenno-meditsinskoj akademii. 2020;39(1):23-28. 
  52. Gao J, Fan RF, Yang JY, et al. Radiofrequency ablation for hepatic hemangiomas: A consensus from a Chinese panel of experts. World J Gastroenterol. 2017;23(39):7077-7086. https://doi.org/10.3748/wjg.v23.i39.7077
  53. Zhang X, Yan L, Li B, et al. Comparison of laparoscopic radiofrequency ablation versus open resection in the treatment of symptomatic-enlarging hepatic hemangiomas: a prospective study. Surg Endosc. 2016;30(2):756-763.  https://doi.org/10.1007/s00464-015-4274-y
  54. van Tilborg AAJM, Dresselaars HF, Scheffer HJ, et al. RF Ablation of Giant Hemangiomas Inducing Acute Renal Failure: A Report of Two Cases. Cardiovasc Intervent Radiol. 2016;39(11):1644-1648. https://doi.org/10.1007/s00270-016-1415-1
  55. Yamashita S, Okita K, Harada K, et al. Giant cavernous hepatic hemangioma shrunk by use of sorafenib. Clin J Gastroenterol. 2013;6(1):55-62.  https://doi.org/10.1007/s12328-012-0343-0
  56. Mahajan D, Miller C, Hirose K, McCullough A, Yerian L. Incidental reduction in the size of liver hemangioma following use of VEGF inhibitor bevacizumab. J Hepatol. 2008;49(5):867-870.  https://doi.org/10.1016/j.jhep.2008.06.028
  57. Ono M, Sawada K, Okumura T. A case of liver hemangioma with markedly reduced tumor size after metformin treatment: a case report. Clin J Gastroenterol. 2017;10(1):63-67.  https://doi.org/10.1007/s12328-016-0705-0

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.